Russia has developed the “first” vaccine against Covid-19, Vladimir Putin announced on Tuesday in a video conference broadcast on television.
The race for the vaccine against the new coronavirus, which has already affected more than 20 million people worldwide and killed more than 736,000 of them, has been on for several months. Currently, around 200 Covid-19 vaccines are under development in several countries, of which around 30 are in advanced stages. These include the Moderna vaccine (United States) and that of the University of Oxford (England), promising to be marketed in a few months.
As a result, millions of potentially saved lives, of course, but not only. The country which releases the first “official” vaccine will also have a real advantage on the geopolitical level.
Russia, of course, has also been working for several months to develop a vaccine of its own. According to Bloomberg, many Russian business leaders and politicians had already had access to an experimental solution to Covid-19 as early as April.
The situation seems to have accelerated since then. In a video conference broadcast across the country, the Russian President announced the completed development of the “first” vaccine against the coronavirus.
“This morning, for the first time in the world, a vaccine against the new coronavirus was recorded,” he said. “I know it’s pretty effective, that it gives long lasting immunity.” The daughter of the Russian president has even already benefited from this vaccine, he said. According to him, she would have had a little fever, “and that’s it.”
The solution will be put into circulation on January 1, according to the national drug registry of the Ministry of Health. By then, several million doses can be produced.
During the last count, Russian health authorities reported 4,945 new cases of coronavirus contamination, bringing the total toll to 897,599 people affected. According to Johns Hopkins University, the benchmark, Russia is now the fourth country in the world hardest hit by the pandemic in terms of infections.
In the meantime, Indonesia has started testing the Chinese coronavirus vaccine candidate developed by the Sinovac Biotech laboratory on more than 1,600 volunteers. Called Coronavac, the latter is one of the few vaccines to be in phase III.
In addition, this vaccine is already being tested with 9,000 people in Brazil. This country remains today the fourth most affected in the world by the pandemic, with more than three million recorded cases and more than 100,000 victims.